18-months Safety Follow-up Study of AADvac1, an Active Tau Vaccine for Alzheimer's Disease (FUNDAMANT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02031198
Recruitment Status : Completed
First Posted : January 9, 2014
Last Update Posted : March 17, 2017
Information provided by (Responsible Party):
Axon Neuroscience SE